Wordt geladen...

Reduced Mortality and Severe Disability Rates in the SENTIS Trial

BACKGROUND AND PURPOSE: The Safety and Efficacy of NeuroFlo Technology in Ischemic Stroke trial showed a trend for reduced all-cause mortality and positive secondary safety end point outcomes. We present further analyses of the mortality and severe disability data from the Safety and Efficacy of Neu...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Schellinger, P.D., Shuaib, A., Köhrmann, M., Liebeskind, D.S., Jovin, T., Hammer, M.D., Sen, S., Huang, D.Y., Solander, S., Gupta, R., Leker, R.R., Saver, J.L.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Neuroradiology 2013
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4156593/
https://ncbi.nlm.nih.gov/pubmed/23828106
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A3613
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!